by Jessica | Sep 27, 2019
With $30 million in series A financing newly acquired from Morningside Ventures, Meissa Vaccines aims to develop the first vaccine for respiratory syncytial virus (RSV) for infants. RSV can cause potentially fatal lung infections in infants and elderly adults. In... by Jessica | Sep 11, 2019
GlaxoSmithKline (GSK) has acquired San Diego-based Sitari Pharmaceuticals. The first company formed under the GSK-Avalon venture collaboration in 2013. Sitari was incubated at COI Pharmaceuticals, the Community of Innovation established by Avalon Ventures. The...